HLH: Hyperinflammation Needs a Trigger Search

Clinical Mastery · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Sepsis, malignancy, liver disease, and other inflammatory states can overlap. Treatment response and new evidence should continually refine the diagnosis.

Immune activation can amplify itself. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

Immune activation can amplify itself. Trigger and immune activation — Infection, malignancy or other drivers; Cytokine signaling — Inflammatory amplification; Multiorgan dysfunction — Interpret the full constellation; Parallel assessment — Search for the trigger and support organs. Ferritin alone does not diagnose HLH. Reassess the combined evidence. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

A dysregulated immune response

HLH is a hyperinflammatory syndrome that can arise through inherited defects or acquired triggers such as infection, malignancy, and autoimmune disease.

Recognize the constellation

Persistent fever, cytopenias, organ enlargement, hepatitis, coagulopathy, and marked inflammatory abnormalities raise concern, especially with progressive organ dysfunction.

Combine findings rather than trusting ferritin

HLH-2004 uses a group of findings including fever, splenomegaly, cytopenias, triglyceride/fibrinogen abnormalities, ferritin, and specialized immune tests. The adult HScore estimates probability from a related clinical/laboratory pattern. Hemophagocytosis can be absent early and is not specific when present.

Investigate trigger and support organs together

Progressive cytopenias, hepatitis, coagulopathy, fever, and organ failure warrant urgent hematology involvement while searching for infection, malignancy, or autoimmune triggers. Do not postpone critical treatment solely to complete every specialized test; document which criteria are met and which competing explanations remain.

Individualize immune treatment

Trigger-directed therapy and immune-modulating treatment must account for infection, organ function, and the clinical trajectory.

Reassess the explanation

Sepsis, malignancy, liver disease, and other inflammatory states can overlap. Treatment response and new evidence should continually refine the diagnosis.

Continue learning